Zoya Zwart
Papers
1
Total Citations
1
H-Index
1
About
Dr. Zoya Zwart is a rising clinical investigator at the intersection of radiation oncology and immunology, with a focused research program on the hematologic consequences of modern radiotherapy. Her most-cited work, a 2024 study on late radiation-related lymphopenia after prostate stereotactic body radiation therapy, establishes her as a leading voice on a critical, under-recognized toxicity. This landmark paper systematically investigates how hypofractionated pelvic irradiation—a technique designed for precision and convenience—can inadvertently compromise lymphocyte counts, potentially affecting both treatment toxicity and long-term cancer control. By quantifying the differential impact of supplemental pelvic fields on immune cell depletion, Dr. Zwart provides actionable data for treatment planning, helping clinicians balance oncologic efficacy with immunologic preservation. Though early in her career, her work has already garnered attention for bridging a crucial gap between dosimetric planning and systemic immune health. Dr. Zwart’s contributions are particularly vital as the field moves toward integrating immunotherapy with radiation, making her research foundational for future combination strategies. Her meticulous approach positions her as a key architect in the emerging discipline of radio-immunobiology.
Research Focus
Key Achievements
Top Papers
- 1